This longer gap increases the risk of appetite return and weight regain, so most providers avoid it unless specifically indicated for side effect management
That approval status is the single biggest difference from CagriSema in this comparison
When combined, the risk of serotonin syndrome, a potentially life-threatening condition, increases, as both medications can influence serotonin levels in the brain. Serotonin might be the bodys feel good chemical, but serotonin syndrome may cause nausea, vomiting, diarrhea, and tremors when its mild or high blood pressure, racing heart rate, seizures, and fainting when its more severe
Tirzepatide (the main component in Mounjaro) is approved for the treatment of obesity, however, when used for weight control the company that makes it (Lilly) calls it Zepbound
A setback on a normal diet can take months or even years to remedy, which can completely discourage the dieter and lead to giving up